• HOME

  • ABOUT

  • PORTFOLIO

    • Fund IV
    • Fund III
    • Fund II
    • Historical
  • _

  • _

  • TEAM.

  • TEAM

  • NEWS

  • CONTACT

  • More

    Use tab to navigate through the menu items.

    A L T I T U D E

    Altitude Life Science Ventures

    Life Science Ventures

    Nuvation Bio
    Nuvation Bio

    NUVB -- SPAC offering February, 2021

    Sana Biotechnology
    Sana Biotechnology

    SANA -- initial public offering February, 2021

    Beam Therapeutics
    Beam Therapeutics

    BEAM -- initial public offering February, 2020

    Lyell Immunopharma
    Lyell Immunopharma

    LYEL -- initial public offering June, 2021

    Vividion Therapeutics
    Vividion Therapeutics

    Acquired by Bayer -- August, 2021

    Neumora Therapeutics
    Neumora Therapeutics

    Developing novel therapeutics using precision medicine approaches to neuroscience drug development

    Nutcracker Therapeutics
    Nutcracker Therapeutics

    Bringing the combined power of high-technology engineering and advanced biosynthesis to RNA therapeutics

    Federation Bio
    Federation Bio

    Developing defined complex microbial communities to provide a robust and lasting cure for high unmet need diseases

    CERo Therapeutics
    CERo Therapeutics

    A cellular immunotherapy company creating a hybrid platform that integrates innate and adaptive programs to eliminate disease

    Iris Medicine
    Iris Medicine

    Developing therapeutics for neurological diseases

    1/1